- Joined
- Apr 16, 2004
- Messages
- 4,667
- Reaction score
- 5,099
I am increasingly seeing prostate cancer patients who had have these tests performed. They are, at times, incongruent with the Gleason Score, PSA, and ultrasound/MRI/DRE results. In those cases, is there any good evidence to escalate treatment?
For instance, if I have a patient who has favorable intermediate risk prostate cancer who would otherwise receive brachytherapy/SBRT is there justification to dose escalate with brachy + IMRT + ADT?
For instance, if I have a patient who has favorable intermediate risk prostate cancer who would otherwise receive brachytherapy/SBRT is there justification to dose escalate with brachy + IMRT + ADT?